Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Platz CoTSE:7813 -1.42%71 Debt-to-Equity is 0.61 as of Jun. 2026, which is 6% below its 10-year median of 0.65. GuruFocus rates TSE:7813 with a GF Score™ of 71/100 and a GF Value™ of 円929.60 (Fairly Valued). The stock has 4 warning signs investors should review. Among 698 Medical Devices & Instruments companies, Platz Co ranks worse than 74.07% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Platz Co's Debt-to-Equity or its related term are showing as below:
TSE:7813'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.56 Med: 0.65 Max: 0.8
Current: 0.61
During the past 13 years, the highest Debt-to-Equity Ratio of Platz Co was 0.80. The lowest was 0.56. And the median was 0.65.
TSE:7813's Debt-to-Equity is ranked worse than 74.07% of 698
companies
in the Medical Devices & Instruments industry
Industry Median: 0.24
vs TSE:7813: 0.61
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Platz Co Debt-to-Equity Related Terms
Platz Co Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Platz Co's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7813 vs ISRG, BDX, RMD: Debt-to-Equity Comparison
For the Medical Instruments & Supplies subindustry, Platz Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Platz Co Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Platz Co's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Platz Co's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Platz Co (TSE:7813) has a Debt-to-Equity of 0.61 as of Jun. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Platz Co and its competitors. This is near median its historical median of 0.65. Over the past decade, Platz Co's Debt-to-Equity has ranged from 0.56 to 0.80. According to the industry distribution chart, Platz Co ranks #517 out of 698 companies in the Medical Devices & Instruments industry, placing it in the top 74.1%.
Is Platz Co's Debt-to-Equity too high?
Platz Co's current Debt-to-Equity of 0.61 is near median its 10-year median of 0.65. Over the past 10 years, this metric has ranged from a low of 0.56 to a high of 0.80. The Medical Devices & Instruments industry median Debt-to-Equity is 0.24. Platz Co's value of 0.61 is 154.2% above this industry median. Based on the distribution chart, Platz Co ranks #517 out of 698 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Platz Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Platz Co's Debt-to-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Platz Co ranks #517 out of 698 companies for Debt-to-Equity. This places Platz Co in the lower half of its industry. The industry median Debt-to-Equity is 0.24. Platz Co's value of 0.61 is 154.2% above this benchmark. Historically, Platz Co's own Debt-to-Equity has ranged from 0.56 to 0.80 over the past decade. While the company's 10-year median is 0.65 vs. the industry median of 0.24, Platz Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.24, based on 698 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Platz Co's current Debt-to-Equity of 0.61 is 154.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Platz Co and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Platz Co's current Debt-to-Equity is 0.61, which is near median its own 10-year median of 0.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Platz Co stock overvalued right now?
Based on GuruFocus' analysis, Platz Co (TSE:7813) is currently considered Fairly Valued. The stock's GF Value™ is 円929.60, compared to a current price of 円900.00 — trading 3.2% below its estimated fair value. The current Debt-to-Equity is 0.61, which is near median its 10-year median of 0.65 and 154.2% above the Medical Devices & Instruments industry median of 0.24. Platz Co's overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Platz Co (TSE:7813), the current Debt-to-Equity is 0.61 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Platz Co (TSE:7813) Overvalued in 2026?
Based on GuruFocus' analysis, Platz Co stock appears to be undervalued.
The current stock price of 円900.00 is trading 3.2% below its estimated GF Value™ of 円929.60.
GuruFocus considers Platz Co to be Fairly Valued.
Key valuation signals for TSE:7813:
Debt-to-Equity: 0.61 (near median its 10-year median of 0.65)
GF Value™: 円929.60 vs. price of 円900.00 (3.2% below fair value)
Industry Position: 154.2% above the Medical Devices & Instruments median (#517 of 698)
No single metric tells the full story. See the TSE:7813 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Platz Co Ltd is engaged in the manufacturing and sales of nursing care beds, mattresses, and other bed-related items. The company's products include nursing care beds, hospital beds, care facility beds, reclining beds, and accessories.
71GF Score
Get the complete analysis for TSE:7813
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7813 has been successfully added to your 
